Compare LRCX & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LRCX | ABT |
|---|---|---|
| Founded | 1980 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9B | 222.8B |
| IPO Year | N/A | N/A |
| Metric | LRCX | ABT |
|---|---|---|
| Price | $165.32 | $121.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 25 | 18 |
| Target Price | ★ $148.09 | $146.61 |
| AVG Volume (30 Days) | ★ 10.9M | 6.4M |
| Earning Date | 01-28-2026 | 01-21-2026 |
| Dividend Yield | 0.64% | ★ 1.93% |
| EPS Growth | 46.65 | ★ 141.97 |
| EPS | 4.53 | ★ 7.96 |
| Revenue | $19,591,788,000.00 | ★ $43,843,000,000.00 |
| Revenue This Year | $17.63 | $7.56 |
| Revenue Next Year | $12.76 | $7.96 |
| P/E Ratio | $35.92 | ★ $15.34 |
| Revenue Growth | ★ 25.66 | 6.37 |
| 52 Week Low | $56.32 | $110.86 |
| 52 Week High | $167.15 | $141.23 |
| Indicator | LRCX | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 62.60 | 33.39 |
| Support Level | $153.15 | $124.06 |
| Resistance Level | $160.10 | $126.05 |
| Average True Range (ATR) | 5.83 | 2.81 |
| MACD | 0.97 | -0.57 |
| Stochastic Oscillator | 99.33 | 0.75 |
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.